Hyperpolarized [1-13C]pyruvate
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Hyperpolarized [1-13C]pyruvate, covering 2024-05-14 to 2026-02-23. Get the full timeline:
Most recent: Clinical Trial Update: Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Renal Tumors [Phase 2]